Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

The endocannabinoid system affects oil production and inflammation in skin cells.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Blocking interferon-gamma might help treat various autoimmune diseases.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Tofacitinib effectively treated both alopecia areata and Crohn's disease in a 12-year-old.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Deleting Crif1 in mouse skin disrupts skin balance and hair growth.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.